Autism Advisory Board Cancels First Meeting After Kennedy Appointments

The Interagency Autism Coordinating Committee (IACC), a federal group advising on autism research and policy, has postponed its first public meeting since new members were appointed earlier this year. No explanation was given for the cancellation, according to a spokesperson for the Department of Health and Human Services.

Andrew Nixon, the HHS spokesperson, stated simply, “The IACC will not meet later this month. Further information will be shared as available.” The news was first reported by Reuters on March 7, 2026.

A Shifting Landscape for Autism Advisory Bodies

The cancellation arrives amid ongoing debate and restructuring within the autism advisory community. Just days prior, a group of scientists established an independent advisory committee in response to concerns about the composition of the federal panel. These concerns stemmed from Health Secretary Robert F. Kennedy Jr.’s appointments, which some researchers believe favor individuals who align with his previously expressed, and debunked, views linking autism to vaccines. Traditionally, the IACC has comprised researchers with mainstream scientific perspectives and autistic self-advocates.

The federal committee had been scheduled to convene on March 19th, marking its first meeting in over a year. The timing of the postponement is particularly notable given the simultaneous launch of the independent group. While the IACC’s next meeting date remains uncertain, a member of the federal panel suggested on social media that a meeting may occur in April.

The Independent Group Moves Forward

Despite the IACC’s postponement, the newly formed independent group will proceed with its planned meeting on March 19th. Helen Tager-Flusberg, a member of this group and director of the Center for Autism Research Excellence at Boston University, confirmed that the meeting will take place as scheduled. This independent effort aims to provide continued scientific guidance on autism issues, operating outside of the recent political considerations surrounding the federal committee.

Understanding the IACC’s Role and Recent Changes

The IACC plays a crucial role in coordinating autism research efforts across various federal agencies. Established by the Combating Autism Act of 2006, the committee is mandated to develop and update a strategic plan for autism research, disseminate information about autism, and advise the Secretary of Health and Human Services on autism-related issues. The committee’s membership includes federal officials, researchers, and, importantly, autistic individuals and family members.

The recent overhaul of the IACC’s membership has sparked considerable controversy. Secretary Kennedy Jr.’s selections have been criticized for lacking transparency and for potentially prioritizing individuals who promote unsubstantiated theories about the causes of autism. This has led to concerns that the committee’s scientific integrity and its ability to provide unbiased recommendations may be compromised. The selection process itself was flagged for a lack of transparency, fueling further distrust.

Debunking the Vaccine-Autism Link

It’s important to reiterate that the claim linking vaccines to autism has been thoroughly debunked by numerous scientific studies. The original study that sparked these concerns, published in 1998 by Andrew Wakefield, was retracted by The Lancet medical journal due to serious methodological flaws and ethical violations. Subsequent research has consistently found no evidence of a causal relationship between vaccines and autism. Organizations like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) unequivocally state that vaccines do not cause autism.

What This Means for Autism Research and Advocacy

The current situation – a postponed federal meeting and the emergence of an independent advisory group – highlights a period of uncertainty for the autism community. The IACC’s strategic plan is a vital document that guides federal funding and research priorities. Delays in its development and implementation could potentially hinder progress in understanding and addressing the complex needs of individuals with autism. The independent group aims to fill this gap, providing a platform for continued scientific discussion and advocacy.

The formation of the independent group similarly underscores the importance of autistic self-advocacy and the demand for diverse perspectives in autism research and policy. Ensuring that autistic individuals and their families are actively involved in shaping the research agenda is crucial for developing interventions and supports that are truly responsive to their needs.

Looking Ahead: Monitoring the Situation

The coming weeks will be critical in determining the future direction of autism advisory efforts. It will be important to monitor whether the IACC is able to reschedule its meeting and address the concerns raised about its membership and transparency. The work of the independent group will also be closely watched, as it seeks to provide a credible and independent source of scientific guidance. Further developments will likely depend on the ongoing dialogue between researchers, advocates, and policymakers.